ALC
Price
$79.44
Change
-$1.92 (-2.36%)
Updated
Aug 28 closing price
Capitalization
39.22B
75 days until earnings call
COO
Price
$64.58
Change
-$9.53 (-12.86%)
Updated
Aug 28 closing price
Capitalization
12.88B
97 days until earnings call
Interact to see
Advertisement

ALC vs COO

Header iconALC vs COO Comparison
Open Charts ALC vs COOBanner chart's image
Alcon
Price$79.44
Change-$1.92 (-2.36%)
Volume$2.17M
Capitalization39.22B
Cooper Companies (The)
Price$64.58
Change-$9.53 (-12.86%)
Volume$14.91M
Capitalization12.88B
ALC vs COO Comparison Chart in %
Loading...
ALC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALC vs. COO commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALC is a Buy and COO is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (ALC: $79.44 vs. COO: $64.58)
Brand notoriety: ALC and COO are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ALC: 113% vs. COO: 584%
Market capitalization -- ALC: $39.22B vs. COO: $12.88B
ALC [@Pharmaceuticals: Other] is valued at $39.22B. COO’s [@Pharmaceuticals: Other] market capitalization is $12.88B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.86B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALC’s FA Score shows that 0 FA rating(s) are green whileCOO’s FA Score has 0 green FA rating(s).

  • ALC’s FA Score: 0 green, 5 red.
  • COO’s FA Score: 0 green, 5 red.
According to our system of comparison, both ALC and COO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALC’s TA Score shows that 4 TA indicator(s) are bullish while COO’s TA Score has 4 bullish TA indicator(s).

  • ALC’s TA Score: 4 bullish, 6 bearish.
  • COO’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ALC is a better buy in the short-term than COO.

Price Growth

ALC (@Pharmaceuticals: Other) experienced а +0.33% price change this week, while COO (@Pharmaceuticals: Other) price change was -11.58% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.91%. For the same industry, the average monthly price growth was +4.90%, and the average quarterly price growth was +15.22%.

Reported Earning Dates

ALC is expected to report earnings on Nov 12, 2025.

COO is expected to report earnings on Dec 04, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.91% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALC($39.2B) has a higher market cap than COO($12.9B). ALC has higher P/E ratio than COO: ALC (36.78) vs COO (31.66). ALC YTD gains are higher at: -6.420 vs. COO (-29.751). ALC has higher annual earnings (EBITDA): 1.53B vs. COO (1.1B). ALC has more cash in the bank: 1.41B vs. COO (116M). COO has less debt than ALC: COO (2.59B) vs ALC (5.2B). ALC has higher revenues than COO: ALC (9.93B) vs COO (3.99B).
ALCCOOALC / COO
Capitalization39.2B12.9B304%
EBITDA1.53B1.1B139%
Gain YTD-6.420-29.75122%
P/E Ratio36.7831.66116%
Revenue9.93B3.99B249%
Total Cash1.41B116M1,217%
Total Debt5.2B2.59B201%
FUNDAMENTALS RATINGS
ALC vs COO: Fundamental Ratings
ALC
COO
OUTLOOK RATING
1..100
761
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
76
Overvalued
PROFIT vs RISK RATING
1..100
62100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
7963
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
4550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALC's Valuation (71) in the Hospital Or Nursing Management industry is in the same range as COO (76) in the Medical Specialties industry. This means that ALC’s stock grew similarly to COO’s over the last 12 months.

ALC's Profit vs Risk Rating (62) in the Hospital Or Nursing Management industry is somewhat better than the same rating for COO (100) in the Medical Specialties industry. This means that ALC’s stock grew somewhat faster than COO’s over the last 12 months.

ALC's SMR Rating (100) in the Hospital Or Nursing Management industry is in the same range as COO (100) in the Medical Specialties industry. This means that ALC’s stock grew similarly to COO’s over the last 12 months.

COO's Price Growth Rating (63) in the Medical Specialties industry is in the same range as ALC (79) in the Hospital Or Nursing Management industry. This means that COO’s stock grew similarly to ALC’s over the last 12 months.

COO's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as ALC (100) in the Hospital Or Nursing Management industry. This means that COO’s stock grew similarly to ALC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALCCOO
RSI
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 1 day ago
61%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
70%
Bearish Trend 1 day ago
56%
Momentum
ODDS (%)
Bearish Trend 1 day ago
44%
Bearish Trend 1 day ago
57%
MACD
ODDS (%)
Bearish Trend 1 day ago
51%
Bearish Trend 1 day ago
57%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
62%
Bearish Trend 1 day ago
59%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
45%
Bearish Trend 1 day ago
59%
Advances
ODDS (%)
Bullish Trend 12 days ago
59%
Bullish Trend 3 days ago
60%
Declines
ODDS (%)
Bearish Trend 1 day ago
56%
Bearish Trend 9 days ago
59%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
51%
Aroon
ODDS (%)
Bearish Trend 1 day ago
48%
Bearish Trend 1 day ago
65%
View a ticker or compare two or three
Interact to see
Advertisement
ALC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IGOV42.430.25
+0.59%
iShares International Treasury Bond ETF
CMCI25.370.11
+0.43%
VanEck® CMCI Commodity Strategy ETF
PNF6.80N/A
N/A
PIMCO NEW YORK Municipal Income FUND
RSJN33.60-0.02
-0.05%
FT Vest U.S. Eq Eq Wght Buffr ETF - Jun
PJP90.78-0.18
-0.20%
Invesco Pharmaceuticals ETF

ALC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALC has been loosely correlated with SYK. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ALC jumps, then SYK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALC
1D Price
Change %
ALC100%
-2.36%
SYK - ALC
54%
Loosely correlated
-0.89%
A - ALC
54%
Loosely correlated
+5.28%
DHR - ALC
53%
Loosely correlated
+0.14%
TMO - ALC
53%
Loosely correlated
+0.33%
IQV - ALC
51%
Loosely correlated
-0.04%
More

COO and

Correlation & Price change

A.I.dvisor indicates that over the last year, COO has been loosely correlated with A. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if COO jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COO
1D Price
Change %
COO100%
-12.85%
A - COO
50%
Loosely correlated
+5.28%
ALC - COO
48%
Loosely correlated
-2.36%
RGEN - COO
47%
Loosely correlated
+2.77%
DHR - COO
46%
Loosely correlated
+0.14%
SYK - COO
44%
Loosely correlated
-0.89%
More